Joslin researchers completed a phase 3 clinical trial of two different classes of oral agents for treating type 2 diabetes in young people aged 10-17 years.

Your Guide to Everything Diabetes Joslin Diabetes Center's staff of physicians, nurses, nutritionists, exercise physiologists, and educat ...

Your privacy is important to us. We use cookies and other tracking technologies to ensure the performance and security of our website and to monitor website use for business and website optimization ...

Melinda is 18-years-old and is currently a freshman at Suffolk University. In her free time, she likes to play lacrosse, go shopping, and go for walks around Boston to places like Newbury Street.

“I’m always happy when patients say, yes, I’m not going out, I’m wearing a mask, I’m doing as much as I can. But it makes it harder for people to meet their fitness goal, which is such a critical ...

Emma Sabourin was a first grader at St. Philomena School in Portsmouth, Rhode Island when she was diagnosed with type 1 diabetes on December 1, 2014.

Initial management with close monitoring appears to provide visual results equal to immediate treatment BOSTON – (April 29, 2019) – Newly available results will influence the standard approach for ...

BOSTON - (March 7, 2019) - SGLT-2 inhibitors are a relatively new class of diabetes drugs that have shown many benefits for people with type 2 diabetes who have not responded well to previous ...

Research in mice links positive effects of diabetes drug with defenses against oxidants. BOSTON – (July 23, 2018) – Researchers have long sought drugs that could help to prevent diabetic kidney ...

Better understanding of signals to burn energy may eventually lead to treatments for obesity. BOSTON – (May 1, 2018) – Sad but true, we don’t all respond equally to exercise. Researchers at Joslin ...

Patient studies suggest that common biological factors may guard against both problems. BOSTON – (January 31, 2018) – In people with type 1 diabetes, high levels of blood glucose eventually can harm ...

Genetic analysis links the hormone GLP-1 with cardiovascular mortality risks. BOSTON – (November 29, 2017) – Scientists at Joslin Diabetes Center have taken another step toward solving a long-standing ...